Biomedical Engineering Reference
In-Depth Information
48. Barnes, C.P., Sell, S.A., Boland, E.D., Simpson, D.G., Bowlin, G.L., 2007,
“Nanofiber technology: Designing the next generation of tissue engineering
scaffolds,” Adv. Drug Deliv. Rev., 59, pp. 1413-1433.
49. Boulaiz, H., Alvarez, P.J., Ramirez, A., Marchal, J.A., Prados, J., et al., 2011,
“Nanomedicine: application areas and development prospects,” Int. J. Mol.
Sci., 12, pp. 3303-3321.
50. Duncan, R., 2003, “The dawning era of polymer therapeutics,” Nat. Rev. Drug
Discov., 2, pp. 347-360.
51. Panyam, J., and Labhasetwar, V., 2003, “Biodegradable nanoparticles for drug
and gene delivery to cells and tissue,” Adv. Drug Deliv. Rev., 55, pp. 329-
347.
52. Couvreur, P., Barratt, G., Fattal, E., Legrand, P., Vauthier, C., 2002,
“Nanocapsule technology: a review,” Crit. Rev. Ther. Drug Carrier Syst., 19,
pp. 99-134.
53. Sawant, R., and Torchilin, V., 2010, “Intracellular transduction using cell-
penetrating peptides,” Mol. Biosyst., 6, pp. 628-640.
54. Musacchio, T. and Torchilin, V.P., 2011, “Recent developments in lipid-based
pharmaceutical nanocarriers,” Front. Biosci., 16, pp. 1388-1412.
55. Stachelek, S.J., Finley, M.J., Alferiev, I.S., Wang, F., Tsai, R.K., et al., 2011, “The
effect of CD47 modified polymer surfaces on inflammatory cell attachment
and activation,” Biomaterials, 32, pp. 4317-4326.
56. Tokarev, I. and Minko, S., 2010, “Stimuli-responsive porous hydrogels at
interfaces for molecular filtration, separation, controlled release, and gating in
capsules and membranes,” Adv. Mater., 22, pp. 3446-3462.
57. Lamprecht, A., Ubrich, N., Yamamoto, H., Schäfer, U., Takeuchi, H., et al.,
2001, “Biodegradable nanoparticles for targeted drug delivery in treatment of
inflammatory bowel disease,” J. Pharmacol. Exp. Ther., 299, pp. 775-781.
58. Choi, C.H., Alabi, C.A., Webster, P., Davis, M.E., 2010, “Mechanism of active
targeting in solid tumors with transferrin-containing gold nanoparticles,” Proc.
Natl. Acad. Sci. U.S.A., 107, pp. 1235-1240.
59. Maeda, H., Wu, J., Sawa, T., Matsumura, Y., Hori, K., 2000, “ Tumor vascular
permeability and the EPR effect in macromolecular therapeutics: a review,”
J. Control Release, 65, pp. 271-284.
60. Chytil, P., Etrych, T., Konak, C., Sirova, M., Mrkvan, T., et al., 2008, “New
HPMA copolymer-based drug carriers with covalently bound hydrophobic
substituents for solid tumour targeting,” J. Control Release, 127, pp. 121-
130.
61. Sahoo, S.K., and Labhasetwar, V., 2005, “Enhanced antiproliferative activity
of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via
sustained intracellular drug retention,” Mol. Pharm., 2, pp. 373-383.
62. Choi, S.H., Lee, S.H., Park, T.G., 2006, “ Temperature-sensitive pluronic/
poly(ethylenimine) nanocapsules for thermally triggered disruption of intra-
cellular endosomal compartment,” Biomacromolecules, 7, pp. 1864-1870.
63. Oishi, M., Kataoka, K., Nagasaki, Y., 2006, “pH-responsive three-layered
PEGylated polyplex micelle based on a lactosylated ABC triblock copolymer
as a targetable and endosome-disruptive nonviral gene vector,” Bioconjug.
Chem., 17, pp. 677-688.
